Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Wiiliam Beaumont Hospital
1921
mi
from 98109
Royal oak, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
1921
mi
from 98109
Royal oak, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
St Louis University
1720
mi
from 98109
St Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
St Louis University
1720
mi
from 98109
St Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Women's Healthcare Specialists of St. Louis LLC
1708
mi
from 98109
St. Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Women's Healthcare Specialists of St. Louis LLC
1708
mi
from 98109
St. Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
The Methodist Hospital Research Institute
1892
mi
from 98109
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
The Methodist Hospital Research Institute
1892
mi
from 98109
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Cooper University Hospital
2375
mi
from 98109
Camden, NJ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Cooper University Hospital
2375
mi
from 98109
Camden, NJ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Lyndhurst Gynecologic Associates
2273
mi
from 98109
Winston Salem, NC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Lyndhurst Gynecologic Associates
2273
mi
from 98109
Winston Salem, NC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Complete Healthcare for Women
2007
mi
from 98109
Columbus, OH
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Complete Healthcare for Women
2007
mi
from 98109
Columbus, OH
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Clinical Trials of America
249
mi
from 98109
Eugene, OR
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Clinical Trials of America
249
mi
from 98109
Eugene, OR
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Thomas Jefferson Hospital
2373
mi
from 98109
Philadelphia, PA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Thomas Jefferson Hospital
2373
mi
from 98109
Philadelphia, PA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Kingsport Perinatology
2151
mi
from 98109
Kingsport, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Kingsport Perinatology
2151
mi
from 98109
Kingsport, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Brown University, Women & Infants Hospital of Rhode Island
2486
mi
from 98109
Providence, RI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Brown University, Women & Infants Hospital of Rhode Island
2486
mi
from 98109
Providence, RI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Perinatal Research Center
1971
mi
from 98109
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Perinatal Research Center
1971
mi
from 98109
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Tenessee Maternal Fetal Medicine
1971
mi
from 98109
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Tenessee Maternal Fetal Medicine
1971
mi
from 98109
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Houston Perinatal Associates
1893
mi
from 98109
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Houston Perinatal Associates
1893
mi
from 98109
Houston, TX
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Status: Archived
Leo W. Jenkins Cancer Center
2426
mi
from 98109
Greenville, NC
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Status: Archived
Updated: 1/1/1970
Leo W. Jenkins Cancer Center
2426
mi
from 98109
Greenville, NC
The Effect of Weight on Vitamin D Dose Response
The Effect of Weight on Vitamin D Dose Response
Status: Archived
Creighton University
1365
mi
from 98109
Omaha, NE
The Effect of Weight on Vitamin D Dose Response
The Effect of Weight on Vitamin D Dose Response
Status: Archived
Updated: 1/1/1970
Creighton University
1365
mi
from 98109
Omaha, NE
A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
D0904 - A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von Hippel-Lindau Disease.
Status: Archived
Darien Pediatric Associates
2414
mi
from 98109
Darien, CT
A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
D0904 - A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von Hippel-Lindau Disease.
Status: Archived
Updated: 1/1/1970
Darien Pediatric Associates
2414
mi
from 98109
Darien, CT
Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
First Use of Parental Support Technology(R) for Single Gene Analysis Plus Aneuploidy Screening in Preimplantation Genetic Diagnosis
Status: Archived
Gene Security Network
701
mi
from 98109
Redwood City, CA
Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
First Use of Parental Support Technology(R) for Single Gene Analysis Plus Aneuploidy Screening in Preimplantation Genetic Diagnosis
Status: Archived
Updated: 1/1/1970
Gene Security Network
701
mi
from 98109
Redwood City, CA
A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis
A Repeat-Dose, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Study to Determine the Safety and Efficacy of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Bluestone Center for Clinical Research
2402
mi
from 98109
New York, NY
A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis
A Repeat-Dose, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Study to Determine the Safety and Efficacy of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Updated: 1/1/1970
Bluestone Center for Clinical Research
2402
mi
from 98109
New York, NY
A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis
A Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study to Determine the Efficacy, Onset, and Duration of Action of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Bluestone Center for Clinical Research
2402
mi
from 98109
New York, NY
A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis
A Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study to Determine the Efficacy, Onset, and Duration of Action of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Updated: 1/1/1970
Bluestone Center for Clinical Research
2402
mi
from 98109
New York, NY
Trial of Minocycline to Treat Children With Fragile X Syndrome
Randomized Double-Blind Controlled Cross Over Trial of Minocycline in Children With Fragile X Syndrome
Status: Archived
University of California, San Francisco, Fresno, School of Medicine
763
mi
from 98109
Fresno, CA
Trial of Minocycline to Treat Children With Fragile X Syndrome
Randomized Double-Blind Controlled Cross Over Trial of Minocycline in Children With Fragile X Syndrome
Status: Archived
Updated: 1/1/1970
University of California, San Francisco, Fresno, School of Medicine
763
mi
from 98109
Fresno, CA
Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
A Double Blind, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo as a Urinary Analgesic for Short Term Treatment in Female Subjects Suffering From Pain or Burning When Passing Urine Associated With Uncomplicated Urinary Tract Infections (uUTI)
Status: Archived
Oxford Pharmaceutical Resources, Inc.
2386
mi
from 98109
Totowa, NJ
Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
A Double Blind, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo as a Urinary Analgesic for Short Term Treatment in Female Subjects Suffering From Pain or Burning When Passing Urine Associated With Uncomplicated Urinary Tract Infections (uUTI)
Status: Archived
Updated: 1/1/1970
Oxford Pharmaceutical Resources, Inc.
2386
mi
from 98109
Totowa, NJ
Topical Cyclosporine Suspension for the Treatment of Brittle Nails
A Single Center, Investigator-blinded Study of the Efficacy of Topical Cyclosporine 0.05% Ophthalmic Suspension (RESTASIS®) Under Occlusion Versus Vehicle in the Treatment of Brittle Nail Syndrome
Status: Archived
University of North Carolina Hospital at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Topical Cyclosporine Suspension for the Treatment of Brittle Nails
A Single Center, Investigator-blinded Study of the Efficacy of Topical Cyclosporine 0.05% Ophthalmic Suspension (RESTASIS®) Under Occlusion Versus Vehicle in the Treatment of Brittle Nail Syndrome
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Updated: 1/1/1970
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Safety and Efficacy of Moxidex Otic
Status: Archived
Alcon Call Center
1665
mi
from 98109
Fort Worth, TX
Safety and Efficacy of Moxidex Otic
Status: Archived
Updated: 1/1/1970
Alcon Call Center
1665
mi
from 98109
Fort Worth, TX
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
Updated: 1/1/1970
Nemours Children's Clinic
2452
mi
from 98109
Jacksonville, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Center for Fetal Medicine
959
mi
from 98109
Los Angeles, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Center for Fetal Medicine
959
mi
from 98109
Los Angeles, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
San Francisco Perinatal Associates
679
mi
from 98109
San Francisco, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
San Francisco Perinatal Associates
679
mi
from 98109
San Francisco, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Women's Clinic
408
mi
from 98109
Boise, ID
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Women's Clinic
408
mi
from 98109
Boise, ID
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Visions Clinical Research
2701
mi
from 98109
Boynton Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Visions Clinical Research
2701
mi
from 98109
Boynton Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Women's Medical Research Group, LLC
2514
mi
from 98109
Clearwater, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Women's Medical Research Group, LLC
2514
mi
from 98109
Clearwater, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Comprehensive Clinical Trials
2691
mi
from 98109
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Comprehensive Clinical Trials
2691
mi
from 98109
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
OB/Gyn Specialists of the Palm Beaches
2692
mi
from 98109
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
OB/Gyn Specialists of the Palm Beaches
2692
mi
from 98109
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
New Mexico Consortium for Perinatal Research
1183
mi
from 98109
Albuquerque, NM
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
New Mexico Consortium for Perinatal Research
1183
mi
from 98109
Albuquerque, NM
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Winthrop University Hospital
2417
mi
from 98109
Mineola, NY
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Winthrop University Hospital
2417
mi
from 98109
Mineola, NY
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Advanced Research Associates
1923
mi
from 98109
Corpus Christi, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Advanced Research Associates
1923
mi
from 98109
Corpus Christi, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Woman's Hospital of Texas
1893
mi
from 98109
Houston, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Woman's Hospital of Texas
1893
mi
from 98109
Houston, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Eastern Va Medical School
2429
mi
from 98109
Norfolk, VA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Eastern Va Medical School
2429
mi
from 98109
Norfolk, VA
Optical Detection of Intravenous Infiltration
Optical Detection of Intravenous Infiltration
Status: Archived
VCU Medical Center
2352
mi
from 98109
Richmond, VA
Optical Detection of Intravenous Infiltration
Optical Detection of Intravenous Infiltration
Status: Archived
Updated: 1/1/1970
VCU Medical Center
2352
mi
from 98109
Richmond, VA
Task-Based Functional MRI (fMRI) in Patients With Severely Bothersome Tinnitus
Task-Based Functional MRI (fMRI) Exploration of the Cortical Attention Network in Patients With Severely Bothersome Tinnitus
Status: Archived
Washington University
1717
mi
from 98109
St. Louis, MO
Task-Based Functional MRI (fMRI) in Patients With Severely Bothersome Tinnitus
Task-Based Functional MRI (fMRI) Exploration of the Cortical Attention Network in Patients With Severely Bothersome Tinnitus
Status: Archived
Updated: 1/1/1970
Washington University
1717
mi
from 98109
St. Louis, MO
An Interactive Informed Consent and Education Program for Pregnant Women
An Interactive Informed Consent and Education Program for Pregnant Women
Status: Archived
Northwestern University
1733
mi
from 98109
Chicago, IL
An Interactive Informed Consent and Education Program for Pregnant Women
An Interactive Informed Consent and Education Program for Pregnant Women
Status: Archived
Updated: 1/1/1970
Northwestern University
1733
mi
from 98109
Chicago, IL
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Phoenix Children's Hospital
1113
mi
from 98109
Phoenix, AZ
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Phoenix Children's Hospital
1113
mi
from 98109
Phoenix, AZ
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
City of Hope Comprehensive Cancer Center
960
mi
from 98109
Duarte, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
960
mi
from 98109
Duarte, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Miller Children's Hospital Long Beach
979
mi
from 98109
Long Beach, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Miller Children's Hospital Long Beach
979
mi
from 98109
Long Beach, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Oakland Children's Hospital
679
mi
from 98109
Oakland, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Oakland Children's Hospital
679
mi
from 98109
Oakland, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Stanford Clinical Research Center
705
mi
from 98109
Stanford, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Stanford Clinical Research Center
705
mi
from 98109
Stanford, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
University of California at San Francisco (UCSF)
682
mi
from 98109
San Francisco, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
682
mi
from 98109
San Francisco, CA